Company: IMXI
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001683695-25-000058
Chunk: 85

Company: International Money Express, Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 85
---
 the following actions with respect to outstanding grants: (i) provide that all outstanding options and SARs will automatically accelerate and become exercisable, in whole or in part, (ii) provide that the restrictions and conditions on all outstanding stock awards will immediately lapse, in whole or in part, (iii) provide that grantees holding outstanding stock units, performance shares, dividend equivalents and other stock-based awards will receive payment in settlement of such award in an amount determined by the Administrator, (iv) require that grantees surrender their outstanding options and SARs in exchange for

| 72 |     | 2025 Proxy Statement |

| PROXY STATEMENT                                                                                    |
| PROPOSAL FOUR - APPROVAL OF AMENDMENT AND RESTATEMENT OF THE 2020 OMNIBUS EQUITY COMPENSATION PLAN |

payment, in cash or shares of common stock as determined by the Administrator, in an amount equal to the amount (if any) by which the then fair market value subject to the grantee’s unexercised options and SARs exceeds the exercise price of the option or the base amount of the SAR, as applicable, or (v) after giving grantees the opportunity to exercise their outstanding options and SARs, the Administrator may terminate any or all unexercised options and SARs at the time the Administrator determines appropriate.

No Repricing of Options or SARs.

Except in connection with a corporate transaction involving the Company (including, without limitation, any stock dividend, stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off, combination, or exchange of shares), the Administrator may not, without stockholder approval, (i) amend the terms of outstanding options or SARs to reduce the exercise price of outstanding options or SARs; (ii) cancel outstanding options or SARs in exchange for options or SARs with an exercise price that is less than the exercise price of the original options or SARs, (iii) when the exercise price exceeds the fair market value of one share, cancel outstanding options or SARs in exchange for cash or other awards, or (iv) take any action with respect to an option or SAR that would be treated as a repricing under the rules and regulations of the principal securities exchange on which the shares are traded.

Amendment and Termination of the A&R 2020 Plan.

Our board of directors may amend or terminate the A&R 2020 Plan at any time, subject to stockholder approval